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Available online 5 December 2014Abstract Neural stem/progenitor cells (NPCs) express a variety of asparagine-linked oligosaccharide chains, called
N-glycans, on the cell surface, and mainly produce hybrid-type and complex-type N-glycans. However, the expression profiles
and roles of N-acetylglucosaminyltransferase-V (GnT-V), an enzyme that forms β1,6-branched N-glycans, in NPCs remain
unknown. In this study, cultured NPCs were prepared from adult or embryo cortex, and were maintained as either proliferating
NPCs or differentiated cells in vitro. Analysis using reverse-transcriptase polymerase chain reaction, Western blot and lectin
blot revealed that GnT-V and its reaction products were distinctly expressed in proliferating NPCs; moreover expression of
GnT-V and its reaction products were markedly diminished in differentiated cells. In brain slices, many GnT-V-positive
neurogenic cells were detected throughout the cerebral cortex on embryonic day 13, while only a few doublecortin (Dcx)- and
GnT-V-double positive NPCs were detected around the subventricular zone of the lateral ventricle in the adult brain. However,
in the mice in which motor function was spontaneously recovered after cryoinjury to the motor cortex, many Dcx- and
GnT-V-double positive NPCs were found to have accumulated around the brain lesion of the adult cerebral cortex compared
with the mice in which the function did not recover. These results indicate that GnT-V expression is under rigorous control
during NPC differentiation. Furthermore, expression of GnT-V and its reaction products in NPCs may be necessary for the
functional recovery after brain injury, and could be used as a marker for visualization of NPCs.
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N-acetylglucosaminyltransferase; L-PHA, Phaseolus vulgaris leucoagglutinating lectin; Man, mannose; N-glycan, asparagine-linked
oligosaccharides; NPCs, neural stem/progenitor cells; PCR, polymerase chain reaction; PVDF, polyvinylidene difluoride; SDS, sodium dodecyl
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69Predominant expression of GnT-V in neural stem/progenitor cellsIntroduction Care and Use of Animals approved by the Council of theAsparagine-linked oligosaccharides (N-glycan) can typically be
classified into a high mannose, complex, or hybrid type,
depending on the extent of processing and/or on the type of
branching (Kleene and Schachner, 2004). The composition of
N-glycan in adult mice differs among organs: the major part of
N-glycan in the adult peripheral organs is complex- and
hybrid-type N-glycan, while the majority of N-glycan in the
adult brain is high mannose-type N-glycan (Chai et al., 1999;
Chen et al., 1998; Zamze et al., 1998). In the adult brain,
neural stem/progenitor cells (NPCs) exist in the subventricular
zone (SVZ) and dentate gyrus, and have a typical stem cell
phenotype, with self-renewal and multipotent capacities
(for reviews see: Anderson, 2001; Gage et al., 1995; McKay,
1997; Okano, 2002). Interestingly, adult NPCs express mainly
hybrid-type and complex-type N-glycans, rather than high
mannose-type N-glycan. In particular, bisected complex-type
N-glycans are expressed on the NPC surface, and are a useful
cell surface marker that can help enrich NPCs via the lectin
panningmethod (Hamanoue et al., 2008, 2009; Hamanoue and
Okano, 2011).
Biosynthesis of both bisected and β1,6-branched
complex-type N-glycans is initiated by the addition of a
single N-acetylglucosamine (GlcNAc) residue to a common
acceptor, typically biantennary oligosaccharide; however,
different glycosyltransferases are responsible for linking
GlcNAc to mannose residues in the trimannosyl core.
N-acetylglucosaminyltransferase (GnT)-III, which is encoded
by the Mgat3 gene, transfers a GlcNAc to β-mannose via
β1,4-linkage, thus leading to the formation of bisecting
GlcNAc. A β1,6-branch is formed by GnT-V, which is encoded
by the Mgat5 gene, thus resulting in conversion to triantennary
oligosaccharide (Saito et al., 1994; Shoreibah et al., 1993).
Another glucosaminyltransferase that synthesizes β1,6-
branched complex-type N-glycans in vitro is GnT-Vb (IX), a
paralog of GnT-V with 53% amino acid similarity (Inamori et
al., 2003; Kaneko et al., 2003). In vivo, GnT-Vb predomi-
nantly transfers GlcNAc via β1,6-linkage to O-mannose type
(O-glycans) but not to N-glycan (Lee et al., 2012). GnT-III,
GnT-V, and GnT-Vb are expressed throughout the brain
(Abbott et al., 2008; Bhattacharyya et al., 2002; Bhaumik et
al., 1995; Inamori et al., 2003; Lee et al., 2012; Partridge et
al., 2004); however, the expression of these GnTs in NPCs
remains unknown. In this study, we examined the expres-
sion of GnTs by PCR analysis, Western blot analysis, and
immunohistochemistry, and revealed the predominant
expression of GnT-V and its reaction products in proliferat-
ing NPCs. Thus, GnT-V and its reaction products could be
novel markers for NPCs in living brain tissue. Furthermore,
experiments using a cryoinjury model suggested that GnT-V
and its reaction products may be necessary for the
functional recovery of damaged brain.
Materials and methods
Materials
Pregnant and adult mice (C57BL/6J) were purchased from
Sankyo Laboratory Service (Tokyo, Japan). All experiments
were performed according to the Guiding Principles for thePhysiological Society of Japan. The Ethics Review Committee
for Animal Experimentation at Toho University also approved
all experimental protocols used in this study (No. 13-53-153).
All chemical reagents were purchased from Sigma-Aldrich Co.
(St. Louis, MO, USA) and Wako Pure Chemicals Industries
(Osaka, Japan) unless otherwise noted. All culture materials
were purchased from Greiner Bio-One (Tokyo, Japan) unless
otherwise noted.
Cell preparation
NPCs were prepared from embryonic day 13 (E13) or adult
[10-week-old (P10w)] mouse brains as previously described
(Hamanoue et al., 2009; Sato et al., 2008) with slight
modifications. In brief, embryonic brains (cerebral hemi-
sphere and thalamus) or adult brains (cerebral hemispheres,
hippocampus, and corpus callosum) were mechanically
dissociated by trituration into single-cell suspensions in
Hanks' balanced salt solutions (HBSS) without Ca2+ or Mg2+.
After washing with Dulbecco's Modified Eagle's Medium
(Nutrient Mixture F-12 Ham (DMEM/F-12 medium)) several
times, the cells were filtered through 70-μm and 40-μm cup
filters (BD Biosciences, Franklin Lakes, NJ, USA). Dissociated
brain cells were cultured in growth-promoting medium
containing DMEM/F-12 medium, B27 supplement (Invitrogen
Corp., Carlsbad, CA, USA), epidermal growth factor (EGF;
20 ng/mL; PeproTech EC, London, UK), basic fibroblast
growth factor (FGF-basic; 20 ng/mL, PeproTech EC) and
penicillin and streptomycin (100 U/mL and 100 μg/mL,
respectively) for seven days. The primary neurosphere was
dispersed by trituration and then replated onto Petri dishes
in the growth-promoting medium for an additional seven
days to obtain secondary neurospheres. NPCs were then
obtained by dissociation of the secondary neurospheres
(Hamanoue et al., 2009; Sato et al., 2008).
The purity of NPCs was estimated by their nestin expression,
and capacity for self-renewal and multipotency (Hamanoue et
al., 2009). Briefly, the differentiation of NPCs was initiated by
culturing them in DMEM/F12 medium with B27 supplement on
poly-L-lysine and laminin-coated dishes for two or five days. The
multipotency for their development into differentiated cells,
including neurons and astrocytes, fromNPCs was ascertained by
a Western blot analysis.
PCR analysis
mRNA was purified from cultured cells via a Qiagen RNeasy kit
according to themanufacturer's instructions (QIAGEN, Valencia,
CA, USA). The cDNA synthesis was performed using reverse
transcriptase (Takara Bio, Inc., Otsu, Japan). For PCR analysis,
we used EX Taq polymerase (Takara Bio, Inc.) with the following
specific primers: GnT-V, 5′-GACCTGCAGTTCCTTCTTCG-3′ and
5′-CCATGGCAGAAGTCCTGTTT-3′; GnT-Vb, 5′-CATGGCACCGT
GTACTAC-3′ and 5′-TCTGGAGCTCTGCAGAAG-3′ (Inamori et
al., 2006); GnT-III, 5′-GGGAAATGTAGTTTTGAGCAGG-3′ and
5′-ACAGACATCTCAGGAGAGAGCC-3′; β-actin, 5′-GACCCAGA
TCATGTTTGAGACC-3′ and 5′-GAGAGCATAGCCCTCGTAGA-3′.
PCR was performed on a thermal cycler (Biometra GmbH,
Göttingen, Germany) using the following parameters: 40 cycles
of PCR (98 °C for 10 s, 60 °C for 30 s, and 72 °C for 60 s). The
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phoresis were visualized under a UV-transilluminator (ATTO
Corporation, Tokyo, Japan).
Western blot analysis and lectin blot analysis
Cells were washed with PBS, and the proteins were obtained
by collecting cells with Laemmli's sample buffer. After
boiling, the protein samples were separated on 2–18%
sodium dodecyl sulfate (SDS)-polyacrylamide gels or 5–15%
Hi-QRAS Neutral gel N (Kanto Chemical Co. Inc., Tokyo,
Japan). The proteins were transferred to polyvinylidene
difluoride (PVDF) membranes, which were then incubated in
Tris-buffered saline containing 5% skim milk and 0.1% Tween
20 or Blocking One-P (Nacalai Tesque Inc., Kyoto, Japan).
After being washed, the membranes were incubated with
the following antibodies: anti-GnT-V (H00004249-A01,
mouse polyclonal, Abnova Co., Taipei, Taiwan), anti-GnT-
III (sc-27276, goat polyclonal IgG, Santa Cruz Biotechnology,
Dallas, USA), anti-GnT-Vb (sc-164500, goat polyclonal IgG,
Santa Cruz Biotechnology), anti-β-actin (sc-47778, mouse
monoclonal IgG1, Santa Cruz Biotechnology), anti-c-Myb
(sc-517, rabbit polyclonal IgG, Santa Cruz Biotechnology),
anti-Ets-1/Ets-2 (sc-112, rabbit polyclonal IgG, Santa Cruz
Biotechnology), anti-nestin (MAB353, mouse monoclonal
IgG1, Millipore Corp., Billerica, USA), anti-GFAP (glial
fibrillary acidic protein, G9269, rabbit polyclonal IgG,
Sigma-Aldrich Co.), and anti-βIII-tubulin (G7121, mouse
monoclonal IgG1, Promega Corp., Madison, USA) for 16 h at
4 °C, followed by incubation with horseradish peroxidase
(HRP)-conjugated goat anti-rabbit IgG, anti-mouse IgG, or
anti-goat IgG (1:1000, Santa Cruz Biotechnology). Chemilu-
minescence signals were developed by the Immunostar LD
kit, and were visualized by the ImageCapture G3 system
(Liponics Inc., Tokyo, Japan).
For lectin blots, samples were prepared as described above,
and the transfer membrane was incubated in a buffer
containing biotin-conjugated L-PHA (Phaseolus vulgaris
leucoagglutinating lectin, 1 μg/ml, EY Laboratories, Inc., San
Mateo, USA) and HRP-streptavidin (GE Healthcare Biosciences
AB, Upsala, Sweden) alter blocking with Blocking One-P. As an
internal standard, the filter was blotted with anti-β-actin
antibody. To ascertain whether L-PHA binds to samples through
oligosaccharide, we treated the protein samples with PNGase
(P0704, New England BioLabs Japan Inc., Tokyo, Japan), which
cleaves between the GlcNAc and asparagine residues of
N-glycans, before subjecting them to SDS-PAGE. The 14-μg
protein samples were treated with 1000 units of PNGase at
37 °C for 1 h, followed by heat inactivation.
We obtained the relative intensities by densitometry
using a computerized analysis system (NIH Image J and the
Odyssey Infrared imaging system, LI-COR Corp., Lincoln,
USA). Statistical evaluations were performed using Student's
t-test, and P b 0.05 was considered to be statistically
significant.
Cryoinjury model
The cryoinjury was induced using the method reported by
Steinbach et al. (1999) with slight modifications. In brief,
mice (8–10 weeks old) were anesthetized with 2,2,2-tribromoethanol (avertin, 0.25 mg/g (Papaioannou and Fox,
1993)). Incisions were made along the midline to expose the
skull. An aluminum probe (3 mm in diameter) was fitted to a
50-ml syringe, which was filled with liquid nitrogen. The
chilled probe was placed on the parietal skull 1.5 mm lateral
to the midline at the bregma for 120 s. The skin was then
sutured, and mice were returned to their cages. To evaluate
the motor function and coordination of the mice, we
administered a rotarod test (Shichinohe et al., 2007), with
some modification. In brief, mice were trained for five weeks
before cryoinjury with program B (80 rpm for a maximum of
180 s, MK-670, Rota-Rod Treadmill for Rats &Mice, Muromachi
Kikai Co., Ltd., Tokyo, Japan). The trial ended when the
mice fell from the rotor or misstepped on the rotor, and the
latency was recorded. Each mouse ran on the rotarod at least
five times, and the three longest times were used for the
analysis.
Histochemical analysis
Immunohistochemistry was performed as described previously
(Hamanoue et al., 2009) with slight modifications. The brains
were removed from paraformaldehyde (PFA)-perfused mice
and further fixed in 4% PFA for 1 h, 15% sucrose for 16 h, and
30% sucrose for 8 h. Cryostat sections (14 μm) of cerebral
cortex were fixed with methanol for 10 min at −20 °C. After
blocking the endogenous peroxidase activity, the sections
were then blocked with Blocking One Histo (Nacalai Tesque
Inc.) for 10 min at room temperature. The slices were
incubated with the following antibodies in 1:20-diluted
Blocking One Histo:anti-doublecortin (mouse IgG1, 611706,
BD Transduction Lab) for progenitor cells (Tamura et al.,
2007), anti-nestin (Millipore) for neurogenic cells and
anti-GnT-V (sc-19088, goat polyclonal IgG, Santa Cruz Bio-
technology). After being washed, the slices were stained with
secondary antibodies conjugated with Alexa Fluor 555-conju-
gated anti-mouse IgG (Molecular Probes, Eugene, OR, USA)
or HRP-conjugated donkey anti-goat IgG and fluorescein-
conjugated TSA (NEN Life Science Products, Inc. Boston, USA).
The nuclei were visualized with 13 ng/mL of 4′,6-diamidino-
2-phenylindole (DAPI). We observed and counted the fluores-
cent signals under a confocal microscope (Nikon Corp., Tokyo,
Japan).
Hematoxylin and eosin staining was performed ac-
cording to the manufacturer's instructions (Merk KGaA,
Darmstadt, Germany). The brain slices were incubated
with Mayer's hemalum solution (109249, Merk KGaA)
and Eosin Y solution (102439, Merk KGaA). We quantified
the wound area using the Adobe Photoshop software
package.
Results
Antigenic characterization of NPCs
NPCs have both self-renewal and multipotent capacities.
To ascertain whether our cultured cells had the capacity
for self-renewal, primary or secondary neurospheres pre-
pared from embryonic and adult mouse brain were dispersed
and reseeded onto Petri dishes. After seven days in vitro,
multiple spheres were detected (data not shown), indicating
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multipotent capacity of our cells was verified by a Western
blot analysis. We prepared the protein samples from cells
under growth-promoting conditions, and conducted a West-
ern blot analysis using antibodies specific for each neuronal
cell type. The growth-promoting cells expressed the nestin
antigen, which is specific for NPCs (Supplemental Fig. 1A,
day 0), but did not express βIII-tubulin or glial fibrillary
acidic protein (GFAP) antigen, which is specific for immature
neurons and astrocytes, respectively (Supplemental Figs. 1B,
C, day 0). To induce differentiation, the growth-promoting
cells were cultured on a poly-L-lysine and laminin-coated
dish in growth factor-deprived medium for two or five days.
A Western blot analysis of these differentiation-promoting
cells showed a decrease in nestin expression and an increase
in the βIII-tubulin- and GFAP-expression (Supplemental
Figs. 1A, B, C, days 2 and 5). These results revealed that
cultured cells obtained from mouse brains have an NPC
phenotype, and are able to differentiate into neurons and
glia in vitro.Changes in GnTs mRNA expression
during differentiation
To estimate the expression level of the enzyme regulating
the N-glycans, mRNA was isolated from adult NPCs and
embryonic NPCs, and reverse transcriptase-polymerase
chain reaction (PCR) amplification was performed using
specific primers for GnTs. All GnT mRNAs, including GnT-III,
GnT-V, and GnT-Vb, were detected in both adult and
embryonic NPCs (Fig. 1, day 0). In the adult NPCs, however,
all GnT mRNA levels were reduced in differentiated cells; in
particular, the levels of GnT-V and GnT-Vb mRNA were
drastically reduced (Fig. 1, adult). In contrast, GnT-III and
GnT-Vb mRNA levels remained unchanged during the
differentiation from embryonic NPCs to differentiated cells
(Fig. 1, embryo), although GnT-V mRNA expression also
dramatically decreased in the differentiating cells derivedFigure 1 GnT-V mRNA is predominantly expressed in prolif-
erating NPCs rather than in differentiated cells. mRNA was
collected from adult or embryonic NPCs under growth-promot-
ing (0 days) or differentiated (2 or 5 days) conditions. Reverse
transcriptase-PCR amplification was performed using GnT-
specific primers. GnT-V mRNA expression was predominantly
expressed in proliferating NPCs.from embryonic NPCs (Fig. 1, embryo). These results
suggest that GnT-V mRNA, but not GnT-III or GnT-Vb mRNA,
is highly regulated in both adult and embryonic NPCs during
differentiation, and indicate that β1,6-branched complex-
type N-glycans, rather than bisecting N-glycans, may play a
role in both adult and embryonic NPCs.Changes in the GnT protein expression
during differentiation
To confirm that the GnT mRNAs are translated into
proteins, protein samples were collected from adult NPCs
and embryonic NPCs under growth-promoting (0 days) or
differentiated (2 or 5 days) conditions, and a Western blot
analysis was performed with anti-GnT antibodies. The
proteins of GnT-III and GnT-V were detected in proliferat-
ing NPCs (Figs. 2A, B, day 0). During the differentiation, the
expression of the GnT-V protein significantly decreased
(Fig. 2B, day 2 and day 5) compared with that of proliferating
NPCs (day 0). In contrast, the expression levels of the GnT-III
protein (Fig. 2A) and β-actin (Fig. 2C) were unchanged during
differentiation. The GnT-Vb protein (110 kDa (Inamori et al.,
2003)), on the other hand, was not detected in our cultured
cells (data not shown). The expression pattern of the GnT-V
protein was in agreement with the expression pattern of the
GnT-V mRNA.
GnT-V transfers GlcNAc to α1,6-linked mannose in the core
via β1,6-linkage, and thereby forms β1,6-branched complex-
type N-glycans. To ascertain whether the GnT-V protein
synthesizes the β1,6-branched type of N-glycans in NPCs,
protein samples from the cells were blotted with L-PHA which
recognizes the pentasaccharide sequence Galβ1-4GlcNAcβ1-
2(Galβ1-4GlcNAcβ1-6)Man, including β1,6-branched complex-
type N-glycans (Cummings and Etzler, 2009). The binding of
biotinylated L-PHA to protein samples was detected using
HRP-streptavidin (Fig. 3A). To calculate the relative intensity
of the L-PHA-binding proteins, the same protein samples were
blotted with anti-β-actin antibody as a loading control
(Fig. 3B). We found that L-PHA bound to many proteins both
in NPCs and in the differentiating cells (Fig. 3A, −PNGase). To
ascertain whether L-PHA binding depended on N-glycans, the
protein samples were treated with PNGase, which cleaves
between the innermost GlcNAc of N-glycans and asparagine
residues of glycoproteins, before subjecting the samples to
SDS-PAGE (Fig. 3A, +PNGase). Some of the binding of L-PHA to
NPCs was diminished by PNGase treatment (Fig. 3A, +PNGase,
arrows, arrowheads), but the band intensity of β-actin was not
influenced by PNGase treatment (Fig. 3B); this indicated
that some of the L-PHA binding proteins (p220, p135, p80,
p70) were glycoproteins with β1,6-branched N-glycans.
Among these glycoproteins, p220 was expressed predomi-
nantly in both adult and embryonic NPCs rather than in the
differentiating cells (Fig. 3A, arrow; Fig. 3C). In addition to
p220, the glycoproteins p135, p80, and p70 were also
predominantly expressed in adult NPCs; however, their
expression levels were higher in differentiated cells than
in embryonic NPCs (Fig. 3A, arrowheads; Figs. 3D–F).
These results suggest that GnT-V and the β1,6-branched
complex-type N-glycans like p220 are predominantly
expressed in NPCs, and play a specific role in both adult
and embryonic NPCs.
Figure 2 The GnT-V protein is predominantly expressed in the proliferating NPCs obtained from the embryonic or adult brain.
Proteins were collected from embryonic or adult NPCs under growth-promoting (0 days) or differentiated (2 or 5 days) conditions.
The Western blot analysis of proteins (20 μg) from NPCs was performed with an anti-GnT-III (A), anti-GnT-V (B), or anti-β-actin
antibody (C). The relative intensities were obtained by densitometry with a computerized analysis system (B). Data represent the
means ± SEM of three independent experiments. *P b 0.05, **P b 0.01, in comparison to the growth-promoting cells. The GnT-V
protein expression (B, arrowhead, 150 kDa) was predominantly expressed in proliferating NPCs obtained from the embryonic or
adult brain.
72 M. Hamanoue et al.GnT-V expression in the brain and in the NPCs that
accumulate around the brain lesions
To ascertain whether NPCs express GnT-V in the brain, we
conducted an immunohistochemical analysis with an anti-GnT-V
antibody. The embryonic brain slices were prepared from E13
mouse hemispheres during the pre-gliogenic period (Delaunay
et al., 2008). Most neurogenic cells express GnT-V and nestin,Figure 3 β1,6-Branched N-glycan is expressed in proliferating NP
collected from embryonic or adult NPCs under growth-promoting (
(14 μg or 5 μg) that were pretreated with/without PNGase were blo
blotted with an anti-β-actin antibody (B), respectively. The relative
(E), p70 (F)) were obtained by densitometry with a computerized
Western blot analysis of β-actin. Data represent the means ± SEM
comparison to the growth-promoting cells. Several β1,6-branched
expressed in NPCs, including p220 (shown as arrow in A, left), p135,
embryo (arrow in A, right). In contrast, several products were pred
including p135, p80 and p70 in the embryo (arrowheads in A, right).and GnT-V-positive cells were detected throughout the brain
(Figs. 4A, B, E13). In contrast, GnT-V expression was restricted
to a few cells in the SVZ of the lateral ventricle in the adult brain
(Fig. 4C, adult, SVZ), and no GnT-V-positive cells were observed
in the motor cortex or cerebral cortex (Fig. 4D, adult, CTX).
These GnT-V-positive cells expressed doublecortin (Fig. 4C,
Dcx); thus, some adult NPCs in the brain express GnT-V, similar
to the cultured NPCs.Cs obtained from the embryonic or adult brain. Proteins were
0 days) or differentiated (2 or 5 days) conditions. The proteins
tted with biotinylated L-PHA lectin and HRP-streptavidin (A) or
intensity of the L-PHA-binding proteins (p220 (C), p135 (D), p80
analysis system and compared to the intensities obtained by
of three independent experiments. *P b 0.05, **P b 0.01, in
N-glycans that were recognized by L-PHA were predominantly
p80 and p70 in the adult (arrowheads in A, left), and p220 in the
ominantly expressed in differentiated cells rather than in NPCs,
73Predominant expression of GnT-V in neural stem/progenitor cellsTo assess the function of GnT-V in NPCs, we prepared
injury-model mice, because the NPCs in the SVZ of injured
mice have been demonstrated to migrate toward the brain
lesion (Kojima et al., 2010). Beginning one week after
cryoinjury of the motor cortex, almost all mice showedimpaired rotarod performance (Supplemental Fig. 2,
65–90% compared with the mice before cryoinjury). A few
mice showed enduring loss of motor function (dotted lines),
and parenchymal deficits in the brain lesion were observed
eight weeks after injury (Figs. 5A, B, asterisk, thin dotted
Figure 4 GnT-V is expressed in the NPCs of the embryonic or adult brain. Brain slices were prepared from E13 (A, B) or adult (C, D)
mice, and an immunohistochemical analysis was performed by treating the samples with an anti-GnT-V, anti-nestin, or anti-Dcx
antibody. The boxed area in (A) is shown at a higher magnification in (B). The GnT-V protein was expressed throughout the brain (A, B,
E13, arrows) and, in particular, GnT-V-positive NPCs in the subventricular zone (C, adult, SVZ, arrows), but it was not expressed in the
cerebral cortex (D, adult, CTX) of the adult brain.
74 M. Hamanoue et al.line). Within these parenchymal deficits, we found a small
cell cluster consisting of hematoxylin-positive cells (Figs.
5A, B, dotted line) in addition to the accumulation of
GnT-V-positive cells (Figs. 5C, D) when compared with the
control mouse brain, which had no injury (Fig. 4D, adult,
CTX). However, the deficit was not filled completely by the
cell cluster because the cluster was too small (Fig. 5A).
Thus, poor Dcx-positive NPC colony formation could
account for the decrease in functional recovery.
On the other hand, a few mice did show spontaneous
functional recovery at 7 weeks after injury (Supplemental Fig.
2, solid lines, 80–106% from the impairment of motor function
detected at one week after injury). In the brains of these
functionally recovered mice, the large size of the bright cell
cluster, which could not be detected in the functionally
impairedmice, was found on the small cell cluster (Figs. 6A, B,
bright cell cluster). The areas of both the bright cell cluster
and small cell cluster in the functionally recovered mice were
significantly larger compared with the cluster area in the
functionally impaired mice (2.5 ± 0.1 fold, n = 3). Since the
bright cell cluster was predominantly stained with anti-Dcx
antibody (Figs. 6C, D), it was considered to be regenerated
tissue, which could compensate for the observed motor
dysfunction. The small cell cluster surrounding the bright
cell cluster was larger compared with that observed in the
functionally impaired mice (Figs. 5A, B); furthermore, many
Dcx- and GnT-V-double-positive cells were also found in this
surrounding cell cluster, but not in the brain parenchyma
(Figs. 6C, D). These results suggest that the accumulation of
GnT-V-positive NPCs in the small cell cluster surrounding the
bright cell cluster could contribute to the reconstitution of
regenerated tissue for the functional recovery of the damaged
brain.Discussion
Predominant expression of GnT-V in NPCsThe cells used in this study fulfilled the criteria for NPCs,
including the ability for self-renewal and the capacity for
multipotency. We demonstrated that GnT-III and GnT-V,
which are both involved in core structure formation of
complex-type N-glycan, are expressed in NPCs prepared
from both adult and embryonic brain samples. These results
are in agreement with previous studies, which have
demonstrated the ubiquitous expression of the Mgat5 gene
throughout the whole body including the adult brain
(Inamori et al., 2003), in addition to the expression of
bisected complex-type N-glycan in NPCs (Hamanoue et al.,
2009). This study also showed that Mgat5 mRNA, GnT-V
protein and its reaction products (e.g., p220) were predom-
inantly expressed in NPCs, and were markedly reduced
during the transition from NPCs to differentiated cells (e.g.,
neurons and glial cells). Taken together with our findings
showing the accumulation of GnT-V-positive NPCs around
regenerated tissue, these results not only suggest that
predominant expression of Mgat5, GnT-V and β1,6-branched
N-glycans, such as p220, could be necessary for the specific
function of NPCs, rather than for differentiated cells, but
that GnT-V and p220 could serve as valuable markers for
visualization of NPCs in living brain tissue. On the other
hand, some of the GnT-V reaction products besides p220
(i.e., p135, p80, p70) were discrepant in their expression
patterns during differentiation between adult NPCs and
embryonic NPCs. Indeed, the expression patterns of GnT-V
reaction products could account for the observed adult
Figure 5 Several GnT-V-positive NPCs slightly accumulated in the small cell cluster of the mice in which motor function had been
impaired by cryoinjury. Mice in which the motor function had been impaired were chosen based on the results of a rotarod test seven
weeks after injury. Brain slices were prepared, and hematoxylin–eosin staining was performed (A, B). The boxed area in (A) is shown
at a higher magnification in (B). Meninges were peeled from the brain surface through the staining procedure. The expected brain
deficit area is shown (thin dotted line and asterisk). A small cell cluster was found on the cerebral parenchyma (A, B).
Immunohistochemical analysis with an anti-GnT-V antibody or anti-Dcx antibody was conducted in brain sections from the injured
mice (C, D). The boxed area in (C) is shown at a higher magnification in (D). The dotted and solid lines show the border between the
small cell cluster and the deficit, and between the small cell cluster and the cerebral parenchyma, respectively (A, B, D). Note that
limited numbers of Dcx-positive cells and GnT-V-positive cells were only detected in this cell cluster (D).
75Predominant expression of GnT-V in neural stem/progenitor cellsbrain-specific features, such as low proliferative and
regenerative abilities.
There have been questions regarding which transcrip-
tional machinery is involved in the specific expression of
GnT-V. Consensus sequences such as LF-A1, HNF1-HP1,
GATA, and Pit-1 (Saito et al., 1995) and the Ets transcription
factor have been reported as transcriptional regulators of
GnT-V (Buckhaults et al., 1997; Kang et al., 1996; Taniguchi
et al., 1999; Yamamoto et al., 2000). However, a Western
blot analysis, which demonstrates Ets-1/Ets-2 expression
both in NPCs and differentiated cells (Supplemental Fig. 3A),
could not support the involvement of Ets transcription in
NPCs. NPC-restricted GnT-V gene expression could be also
regulated by histone modifications through CTCF and
NeuroD1, which have been observed in GnT-Vb gene
regulation (Kizuka et al., 2011). The expression pattern of
GnT-Vb mRNA was inconsistent with that of GnT-V mRNA in
embryonic NPCs (Fig. 1), however, suggesting that other
factors may contribute to GnT-V regulation. To identify
other candidate factor(s), we focused on the transcription
factor binding sites in the promoter region of GnT-V. The
promoter region contains several c-myb binding sites, and
c-myb expression in the adult brain has been previously
reported (Shin et al., 2001). In addition, mice lacking
c-myb have shown a decrease in neurogenesis (Malaterre et
al., 2008), prompting us to investigate whether c-myb
could act as a transcription factor specific for GnT-V. In
fact, a Western blot analysis of our cultured NPCs showed
that c-myb appeared to be predominantly expressed in
adult NPCs compared to the differentiated cells (Supple-
mental Fig. 3B). These findings suggest that c-myb could bea major contributor to GnT-V regulation. Thus further
investigation of NPC-restricted gene regulation will be
necessary for future application in stem cell biology,
including the development of a NPC-specific gene expres-
sion system.Function of GnT-V in NPCs
This study demonstrated that both mRNA and protein for
GnT-V are expressed in NPCs (Figs. 1, 2). GnT-V synthesizes
β1,6-branched glycan by acting as a glycosyltransferase in
the Golgi apparatus in the cells (Pierce et al., 1987);
furthermore, the secreted soluble form of GnT-V with a
molecular weight less than 100 kDa serves to promote
angiogenesis by releasing fibroblast growth factor-2 (Saito
et al., 2002). Since our Western blot analysis showed a
molecular weight of about 150 kDa for GnT-V expressed in
the cultured NPCs (Fig. 2), it is more likely that GnT-V
functions as a glycosyltransferase inside cells. In addition,
our previous study demonstrated that NPCs can be selec-
tively enriched by lectin-coated plates (Hamanoue et al.,
2008) or by flow cytometry using E-PHA, which recognizes
bisected N-glycan (Yamashita et al., 1983), but not using
L-PHA, which recognizes a β1,6-branch structure (Hamanoue
et al., 2009). These studies also support the suggestion that
GnT-V and its reaction products, β1,6-branched N-glycans,
in NPCs could contribute to the regulation of intrinsic
biological events such as cell migration and proliferation,
rather than extrinsic events such as cell–cell attachment
and recognition by other cells.
Figure 6 Many GnT-V and Dcx-double positive NPCs accumulated in the surrounding area of the regenerated tissue in the mice in
which motor function had been spontaneously restored. Seven weeks after cryoinjury, mice in which the motor function had been
restored were chosen based on the results of a rotarod test. Brain slices were prepared, and hematoxylin–eosin staining of the cortex
was performed (A, B). The boxed area in (A) is shown at a higher magnification in (B). Dotted and solid lines show the border between
the bright cell cluster and the small cell cluster, and between the small cell cluster and the cerebral parenchyma, respectively. There
was a large bright cell cluster and small cell cluster on the brain parenchyma (A, B). An immunohistochemical analysis with an
anti-GnT-V antibody or anti-Dcx antibody reveals the presence of Dcx-positive cells predominantly in the bright cell layer (C, D). Many
GnT-V- and Dcx-double positive cells were detected in the surrounding cell cluster below the bright cell layer (C, D).
76 M. Hamanoue et al.In cancer cells, GnT-V has been demonstrated to be
involved in cell growth and migration by regulating integrins
(Gu et al., 2009; Miyoshi et al., 2012), in epithelial–
mesenchymal transition and tumor metastasis as a rate
limiting step for cytokine receptor signaling (Partridge et
al., 2004), and in determining the invasiveness of glioma
cells (Yamamoto et al., 2000). Since NPC migration is likely
necessary for normal brain development (Cayre et al., 2009;
Huang, 2009), and GnT-V was expressed in the NPCs of the
embryonic brain when NPC migration frequently occurred
(Fig. 4), we hypothesized that GnT-V in NPCs could
participate in cell migration during both normal develop-
ment and pathological conditions, such as brain injury. From
a study using mice lacking both the Mgat5 and Mgat5B genes,
GnT-V protein expression appears to be non-essential fornormal brain development, whereas both N-linked and
O-Man-linked β1,6-branched glycans is totally lost (Lee et
al., 2012). However, during pathological critical conditions,
such as the cryoinjury model used in this study, we detected
the increased accumulation of NPCs in the surrounding cell
cluster of the regenerated-bright cell cluster in the
functionally recovered adult brain. These results may
indicate an association between the functional recovery
from brain injury and GnT-V-positive NPC accumulation,
probably due to the enhancement of cell migration from the
brain parenchyma to the brain lesion. Similar expression
patterns of GnT-V and c-myb, which maintain neurogenesis
and cell cycle progression in NPCs (Malaterre et al., 2008),
may also support a role of GnT-V in NPCs. Further
verification of the direct relationship between NPC
77Predominant expression of GnT-V in neural stem/progenitor cellsaccumulation (i.e., migration and proliferation) with GnT-V
expression and with the reaction products of GnT-V will be
necessary to evaluate this hypothesis.
Conclusions
GnT-V and its reaction products, such as p220, are
predominantly expressed in NPCs rather than in differenti-
ated cells, including neurons or glia. These results indicate
that the expression of GnT-V is under rigorous control of the
transcription mechanism, possibly by c-Myb, and suggest
that GnT-V and its reaction products might play a specific
role in NPCs. Furthermore, the lectin and cryoinjury
experiments suggest that further verification of the direct
relationship of NPC accumulation (migration and prolifera-
tion) with GnT-V and the reaction products of GnT-V will be
necessary for the development of improved therapy
employing the activation of endogenous NPCs. Finally, our
results indicate that GnT-V and its reaction products could
serve as marker for visualization of NPCs in the living brain
tissue, a novel finding and asset to the basic research field.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.11.004.
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